Tesofensine

In plain English

Tesofensine is a small molecule, sold alongside peptides, that keeps three brain chemicals (dopamine, norepinephrine and serotonin) active for longer. That reduces appetite and slightly raises energy use. It was first developed for Parkinson’s and Alzheimer’s disease, where researchers noticed strong weight loss.

What it's used for

  • Weight loss
  • Appetite control

Benefits

In human studies, tesofensine produced about 4.5%, 9.2% and 10.6% more weight loss than placebo at 0.25, 0.5 and 1 mg daily over 24 weeks, along with smaller waists. Users report strong appetite control.

How it works

In simple terms: it keeps the brain’s “satisfied” and “alert” chemicals around longer.

It blocks the reuptake of dopamine, norepinephrine and serotonin, so more of each stays active between nerve cells. This reduces hunger, increases fullness and slightly raises energy expenditure.

Development history

  • 2000s: Developed by NeuroSearch (Denmark) for Parkinson’s and Alzheimer’s disease.
  • 2008: Phase 2 weight-loss results published in The Lancet.
  • Later: Rights moved to Saniona, with phase 3 work in Mexico.

Typical protocols

Educational information only, not medical advice. The information below describes how this peptide has been used in research, on prescription labels or by users. It is not a recommendation. Talk to a qualified healthcare professional before starting, stopping or changing anything.

Doses come from clinical trials; users report similar ranges.

Use Dose Frequency
Weight loss 0.25–0.5 mg (1 mg studied) Daily

Cycling

Studied as a continuous treatment over 24 weeks or more. Because it lasts about 9 days in the body, levels build up over the first few weeks.

Administration options

Subcutaneous injection.

Reconstitution and dosing calculator

Usually comes in 5 mg vials, mixed with 2–5 mL of bacteriostatic water. Doses are small, so check the units carefully.

1Peptide in the vial

The total amount printed on the vial label.

2Bacteriostatic water added

More water makes each dose a bigger, easier-to-measure draw. It does not change how much peptide is in the vial.

3Dose per injection

Use the dose from your protocol or your clinician. 1 mg = 1,000 mcg.

4Your syringe

All three are U-100 insulin syringes: 100 units = 1 mL. Smaller barrels make small doses easier to read.

Draw your syringe to

– units

Volume to draw
–
Concentration
–
Each unit holds
–
Doses per vial
–
Show the math

    This tool does arithmetic only. It does not choose a dose or confirm that any substance is right for you. Double-check every result against your syringe and your clinician’s instructions.

    Side effects and safety

    • Common: dry mouth, trouble sleeping, constipation, nausea and headache.
    • Raises heart rate and can raise blood pressure; people with heart disease or high blood pressure should avoid it.
    • Mood changes, anxiety or agitation.
    • Should not be combined with antidepressants, stimulants or MAO inhibitors.
    • Avoid during pregnancy and breastfeeding.

    Common stacks

    Usually used alone. Combining it with other stimulating compounds raises cardiovascular risk.

    Storage

    Powder: refrigerate or freeze. After mixing: refrigerate at 2–8 °C and use within about 4 weeks.

    Compare with

    • GLP-1 medicines such as semaglutide and tirzepatide: reduce appetite through gut hormones, with much more human data.
    • 5-Amino-1MQ and SLU-PP-332: aim at fat burning rather than appetite.

    Frequently asked questions

    Why does it take a while to work?

    Its 9-day half-life means levels build up over a few weeks before reaching a steady state.

    References

    1. Astrup A, et al. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9653):1906-1913.
    Educational information only. Not medical advice. Always consult a qualified healthcare professional.

    More posts